-
1
-
-
0344076348
-
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: A n overview of 6,633 patients from 27 randomized trials
-
Myeloma Trialists' Collaborative Group.
-
Myeloma Trialists' Collaborative Group. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: A n overview of 6,633 patients from 27 randomized trials. J Clin Oncol 1998, 16: 3832-3842.
-
(1998)
J Clin Oncol
, vol.16
, pp. 3832-3842
-
-
-
2
-
-
0036017506
-
Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma
-
Schwarzenbach H. Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma. Med Oncol 2002, 19: 87-104.
-
(2002)
Med Oncol
, vol.19
, pp. 87-104
-
-
Schwarzenbach, H.1
-
3
-
-
58349111862
-
Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7
-
Sen T, Moulik S, Dutta A, Choudhury PR, Banerji A, Das S and Roy M, et al. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci 2009, 84: 194-204.
-
(2009)
Life Sci
, vol.84
, pp. 194-204
-
-
Sen, T.1
Moulik, S.2
Dutta, A.3
Choudhury, P.R.4
Banerji, A.5
Das, S.6
Roy, M.7
-
4
-
-
56349124779
-
Biocatalytically oligomerized epicatechin with potent and specific anti-proliferative activity for human breast cancer cells
-
Nagarajan S, Nagarajan R, Braunhut SJ, Bruno F, McIntosh D, Samuelson L and Kumar J. Biocatalytically oligomerized epicatechin with potent and specific anti-proliferative activity for human breast cancer cells. Molecules 2008, 13: 2704-2716.
-
(2008)
Molecules
, vol.13
, pp. 2704-2716
-
-
Nagarajan, S.1
Nagarajan, R.2
Braunhut, S.J.3
Bruno, F.4
McIntosh, D.5
Samuelson, L.6
Kumar, J.7
-
5
-
-
0035542950
-
Nuclear factor-kB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue
-
Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H and Nakamura K, et al. Nuclear factor-kB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 2001, 7: 4136-4142.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 4136-4142
-
-
Sasaki, N.1
Morisaki, T.2
Hashizume, K.3
Yao, T.4
Tsuneyoshi, M.5
Noshiro, H.6
Nakamura, K.7
-
6
-
-
58849164440
-
Inhibition of NF-kB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate
-
Ma G, Tabanca N, Husnu Can Baser K, Kirimer N, Pasco DS, Khan IA and Khan SI. Inhibition of NF-kB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate. Cancer Chemother Pharmacol 2009, 63: 673-680.
-
(2009)
Cancer Chemother Pharmacol
, vol.63
, pp. 673-680
-
-
Ma, G.1
Tabanca, N.2
Husnu Can Baser, K.3
Kirimer, N.4
Pasco, D.S.5
Khan, I.A.6
Khan, S.I.7
-
7
-
-
0030747128
-
NF-kB as a frequent target for immunosuppressive and anti-inflammatory molecules
-
Baeuerle PA and Baichwal VR. NF-kB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 1997, 65: 111-137.
-
(1997)
Adv Immunol
, vol.65
, pp. 111-137
-
-
Baeuerle, P.A.1
Baichwal, V.R.2
-
8
-
-
10744222962
-
Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kB activation in human gastric carcinoma cells
-
Nakahara C, Nakamura K, Yamanaka N, Baba E, Wada M, Matsunaga H and Noshiro H, et al. Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kB activation in human gastric carcinoma cells. Clin Cancer Res 2003, 9: 5409-5416.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 5409-5416
-
-
Nakahara, C.1
Nakamura, K.2
Yamanaka, N.3
Baba, E.4
Wada, M.5
Matsunaga, H.6
Noshiro, H.7
-
9
-
-
11844251170
-
The NF-kB/IkB signaling system: A molecular target in breast cancer therapy
-
Wu JT and Kral JG. The NF-kB/IkB signaling system: A molecular target in breast cancer therapy. J Surg Res 2005, 123: 158-169.
-
(2005)
J Surg Res
, vol.123
, pp. 158-169
-
-
Wu, J.T.1
Kral, J.G.2
-
10
-
-
0034655603
-
Green tea polyphenol epigallocatechin- 3-gallate differentially modulates nuclear factor kB in cancer cells versus normal cells
-
Ahmad N, Gupta S and Mukhtar H. Green tea polyphenol epigallocatechin- 3-gallate differentially modulates nuclear factor kB in cancer cells versus normal cells. Arch Biochem Biophys 2000, 376: 338-346.
-
(2000)
Arch Biochem Biophys
, vol.376
, pp. 338-346
-
-
Ahmad, N.1
Gupta, S.2
Mukhtar, H.3
-
11
-
-
0035451363
-
Molecular mechanisms underlying chemopreventive activities of antiinflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-kB activation
-
Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK and Lee SS. Molecular mechanisms underlying chemopreventive activities of antiinflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-kB activation. Mutat Res 2001, 480-481: 243-268.
-
(2001)
Mutat Res
, vol.480-481
, pp. 243-268
-
-
Surh, Y.J.1
Chun, K.S.2
Cha, H.H.3
Han, S.S.4
Keum, Y.S.5
Park, K.K.6
Lee, S.S.7
-
12
-
-
1942532874
-
Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kB and induction of apoptosis
-
Gupta S, Hastak K, Afaq F, Ahmad N and Mukhtar H. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kB and induction of apoptosis. Oncogene 2004, 23: 2507-2522.
-
(2004)
Oncogene
, vol.23
, pp. 2507-2522
-
-
Gupta, S.1
Hastak, K.2
Afaq, F.3
Ahmad, N.4
Mukhtar, H.5
-
13
-
-
62249112196
-
Growth inhibition of prostate cancer cells by epigallocatechin-3-gallate in the presence of Zn2+ in vitro
-
Zhang LC, Shen SR, Sun SL, Yang JG, He GQ and Yu HN. Growth inhibition of prostate cancer cells by epigallocatechin-3-gallate in the presence of Zn2+ in vitro. Fen Zi Xi Bao Sheng Wu Xue Bao 2008, 41: 443-449.
-
(2008)
Fen Zi Xi Bao Sheng Wu Xue Bao
, vol.41
, pp. 443-449
-
-
Zhang, L.C.1
Shen, S.R.2
Sun, S.L.3
Yang, J.G.4
He, G.Q.5
Yu, H.N.6
-
14
-
-
56849103869
-
Epigallocatechin-3-gallate induces apoptosis in human hepatocellular carcinoma cells
-
Chen XL, Wang Q, Cao LQ, Huang XH, Fu XH, Tan HX and Zhen MC, et al. Epigallocatechin-3-gallate induces apoptosis in human hepatocellular carcinoma cells. Zhonghua Yi Xue Za Zhi 2008, 88: 2524-2528.
-
(2008)
Zhonghua Yi Xue Za Zhi
, vol.88
, pp. 2524-2528
-
-
Chen, X.L.1
Wang, Q.2
Cao, L.Q.3
Huang, X.H.4
Fu, X.H.5
Tan, H.X.6
Zhen, M.C.7
-
15
-
-
56749155833
-
(2)-Epigallocatechin-3-gallate potentiates the cytotoxicity induced by benzyl isothiocyanate and hydrogen peroxide in human Jurkat T lymphocytes
-
Wu H, Yokoyama T, Zhu B, Shimoishi Y, Murata Y and Nakamura Y. (2)-Epigallocatechin-3-gallate potentiates the cytotoxicity induced by benzyl isothiocyanate and hydrogen peroxide in human Jurkat T lymphocytes. Biosci Biotechnol Biochem 2008, 72: 3034-3037.
-
(2008)
Biosci Biotechnol Biochem
, vol.72
, pp. 3034-3037
-
-
Wu, H.1
Yokoyama, T.2
Zhu, B.3
Shimoishi, Y.4
Murata, Y.5
Nakamura, Y.6
-
16
-
-
58549106545
-
Suppression of androgen receptor signaling and prostate specific antigen expression by (2)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells
-
Chuu CP, Chen RY, Kokontis JM, Hiipakka RA and Liao S. Suppression of androgen receptor signaling and prostate specific antigen expression by (2)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells. Cancer Lett 2009, 275: 86-92.
-
(2009)
Cancer Lett
, vol.275
, pp. 86-92
-
-
Chuu, C.P.1
Chen, R.Y.2
Kokontis, J.M.3
Hiipakka, R.A.4
Liao, S.5
-
17
-
-
84954358261
-
Time-dependent intracellular trafficking of FITC-conjugated epigallocatechin-3-O-gallate in L-929 cells
-
Han DW, Matsumura K, Kim B and Hyon SH. Time-dependent intracellular trafficking of FITC-conjugated epigallocatechin-3-O-gallate in L-929 cells. Bioorg Med Chem 2008, 16: 9652-9659.
-
(2008)
Bioorg Med Chem
, vol.16
, pp. 9652-9659
-
-
Han, D.W.1
Matsumura, K.2
Kim, B.3
Hyon, S.H.4
-
18
-
-
0035914138
-
Green tea constituent (2)-epigallocatechin-3-gallate inhibits topoisomerase i activity in human colon carcinoma cells
-
Berger SJ, Gupta S, Belfi CA, Gosky DM and Mukhtar H. Green tea constituent (2)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells. Biochem Biophys Res Commun 2001, 288: 101-105.
-
(2001)
Biochem Biophys Res Commun
, vol.288
, pp. 101-105
-
-
Berger, S.J.1
Gupta, S.2
Belfi, C.A.3
Gosky, D.M.4
Mukhtar, H.5
-
19
-
-
59849112850
-
(2)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor
-
Yin Z, Henry EC and Gasiewicz TA. (2)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor. Biochemistry 2009, 48: 336-345.
-
(2009)
Biochemistry
, vol.48
, pp. 336-345
-
-
Yin, Z.1
Henry, E.C.2
Gasiewicz, T.A.3
-
20
-
-
13744262340
-
Lysosome is a primary organelle in B cell receptormediated apoptosis: A n indispensable role of Syk in lysosomal function
-
He J, Tohyama Y, Yamamoto K, Kobayashi M, Shi Y, Takano T and Noda C, et al. Lysosome is a primary organelle in B cell receptormediated apoptosis: A n indispensable role of Syk in lysosomal function. Genes Cells 2005, 10: 23-35.
-
(2005)
Genes Cells
, vol.10
, pp. 23-35
-
-
He, J.1
Tohyama, Y.2
Yamamoto, K.3
Kobayashi, M.4
Shi, Y.5
Takano, T.6
Noda, C.7
-
21
-
-
0043067996
-
Role of p53 and NF-kB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells
-
Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML and Mukhtar H. Role of p53 and NF-kB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 2003, 22: 4851-4859.
-
(2003)
Oncogene
, vol.22
, pp. 4851-4859
-
-
Hastak, K.1
Gupta, S.2
Ahmad, N.3
Agarwal, M.K.4
Agarwal, M.L.5
Mukhtar, H.6
-
22
-
-
1242327925
-
The establishment of three human myeloma cell lines
-
Zhang H and Guo R. The establishment of three human myeloma cell lines. Chin J Cell Biol 1998, 2: 88.
-
(1998)
Chin J Cell Biol
, vol.2
, pp. 88
-
-
Zhang, H.1
Guo, R.2
-
24
-
-
0021118703
-
Quantitative analysis of dose-effect relationships: T he combined effects of multiple drugs or enzyme inhibitors
-
Chou TC and Talalay P. Quantitative analysis of dose-effect relationships: T he combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984, 22: 27-55.
-
(1984)
Adv Enzyme Regul
, vol.22
, pp. 27-55
-
-
Chou, T.C.1
Talalay, P.2
-
25
-
-
34548551073
-
Induction of apoptosis by epigallocatechin-3- gallate in human lymphoblastoid B cells
-
Noda C, He J, Takano T, Tanaka C, Kondo T, Tohyama K and Yamamura H, et al. Induction of apoptosis by epigallocatechin-3- gallate in human lymphoblastoid B cells. Biochem Biophys Res Commun 2007, 362: 951-957.
-
(2007)
Biochem Biophys Res Commun
, vol.362
, pp. 951-957
-
-
Noda, C.1
He, J.2
Takano, T.3
Tanaka, C.4
Kondo, T.5
Tohyama, K.6
Yamamura, H.7
-
26
-
-
0031815389
-
Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols
-
Yang GY, Liao J, Kim K, Yurkow EJ and Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 1998, 19: 611-616.
-
(1998)
Carcinogenesis
, vol.19
, pp. 611-616
-
-
Yang, G.Y.1
Liao, J.2
Kim, K.3
Yurkow, E.J.4
Yang, C.S.5
-
27
-
-
0032516721
-
Induction of apoptosis in prostate cancer cell lines by the green tea component, (2)-epigallocatechin-3-gallate
-
Paschka AG, Butler R and Young CY. Induction of apoptosis in prostate cancer cell lines by the green tea component, (2)-epigallocatechin-3-gallate. Cancer Lett 1998, 130: 1-7.
-
(1998)
Cancer Lett
, vol.130
, pp. 1-7
-
-
Paschka, A.G.1
Butler, R.2
Young, C.Y.3
-
28
-
-
0034668149
-
Nuclear factor-kB, cancer, and apoptosis
-
Bours V, Bentires-Alj M, Hellin AC, Viatour P, Robe P, Delhalle S and Benoit V, et al. Nuclear factor-kB, cancer, and apoptosis. Biochem Pharmacol 2000, 60: 1085-1089.
-
(2000)
Biochem Pharmacol
, vol.60
, pp. 1085-1089
-
-
Bours, V.1
Bentires-Alj, M.2
Hellin, A.C.3
Viatour, P.4
Robe, P.5
Delhalle, S.6
Benoit, V.7
-
29
-
-
0034668151
-
Apoptosis and nuclear factor-kB: A tale of association and dissociation
-
Aggarwal BB. Apoptosis and nuclear factor-kB: A tale of association and dissociation. Biochem Pharmacol 2000, 60: 1033-1039.
-
(2000)
Biochem Pharmacol
, vol.60
, pp. 1033-1039
-
-
Aggarwal, B.B.1
-
30
-
-
33750632876
-
Specific killing of multiple myeloma cells by (2)-epigallocatechin-3- gallate extracted from green tea: Biologic activity and therapeutic implications
-
Shammas MA, Neri P, Koley H, Batchu RB, Bertheau RC, Munshi V and Prabhala R, et al. Specific killing of multiple myeloma cells by (2)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications. Blood 2006, 108: 2804-2810.
-
(2006)
Blood
, vol.108
, pp. 2804-2810
-
-
Shammas, M.A.1
Neri, P.2
Koley, H.3
Batchu, R.B.4
Bertheau, R.C.5
Munshi, V.6
Prabhala, R.7
-
31
-
-
0037973279
-
A phase 2 study of bortezomib in relapsed, refractory myeloma
-
Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D and Rajkumar SV, et al. A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 2003, 348: 2609-2617.
-
(2003)
N Engl J Med
, vol.348
, pp. 2609-2617
-
-
Richardson, P.G.1
Barlogie, B.2
Berenson, J.3
Singhal, S.4
Jagannath, S.5
Irwin, D.6
Rajkumar, S.V.7
-
32
-
-
66949155833
-
Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors
-
Golden EB, Lam PY, Kardosh A, Gaffney KJ, Cadenas E, Louie SG and Petasis NA, et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009, 113: 5927-5937.
-
(2009)
Blood
, vol.113
, pp. 5927-5937
-
-
Golden, E.B.1
Lam, P.Y.2
Kardosh, A.3
Gaffney, K.J.4
Cadenas, E.5
Louie, S.G.6
Petasis, N.A.7
|